Am. J. Respir. Crit. Care Med., Volume 158, Number 4, October 1998, 1047-1051

High Seroprevalence of Helicobacter pylori in Active Bronchiectasis

KENNETH W. TSANG, SHIU-KUM LAM, WAH-KIT LAM, JOHAN KARLBERG, BENJAMIN C. WONG, WAYNE H. HU, WING-WAI YEW, and MARY S. IP

University Departments of Medicine and Paediatrics, University of Hong Kong, Queen Mary Hospital; and Tuberculosis and Chest Unit, Grantham Hospital, Hong Kong

Helicobacter pylori causes chronic inflammation of the gastric mucosa and has been identified in tracheobronchial secretions. Serum IgG against H. pylori was therefore measured prospectively in consecutive subjects with bronchiectasis (n = 100; mean age ± SD 55.1 ± 16.7 yr), active pulmonary tuberculosis (n = 87; age, 57.3 ± 19.1 yr), and healthy volunteers (n = 94; age, 54.6 ± 7.6 yr). Seropositivity was found in 76.0% of bronchiectatic subjects, which was significantly higher than that of the control (54.3%, p = 0.001) and tuberculous (52.9%, p = 0.0001) groups. Multiple logistic regression, adjusted for age, sex, occupational social class, and number of persons living in the household, showed that H. pylori IgG levels of the bronchiectatic group were still significantly higher than that of the control (p = 0.0014) and tuberculous (p = 0.0154) groups. Multiple regression analysis revealed associations between H. pylori serology and sputum volume (p = 0.03) and age (p = 0.001) in the bronchiectatic patients, but not lung function indices or causes of bronchiectasis. The H. pylori seroprevalence in bronchiectasis was significantly (p = 0.0002) higher in patients who produced more (83.1%) than those who produced less than 5 ml sputum/24 h (58.6%). This is the first report of a high H. pylori seroprevalence in bronchiectasis which appears to be specific. Further studies are indicated to evaluate the possible pathogenic role of H. pylori in bronchiectasis.

This article has been cited by other articles:

				K W Tsang, K C Tan, P L Ho, G C Ooi, J C Ho, J Mak, G L Tipoe, C Ko, C Yan, W K Lam, et al. Inhaled fluticasone in bronchiectasis: a 12 month study Thorax, March 1, 2005; 60(3): 239 - 243. [Abstract] [Full Text] [PDF]

				S. L. Chan, M. M. Chan-Yeung, G. C. Ooi, C. L. Lam, T. F. Cheung, W. K. Lam, and K. W. Tsang Validation of the Hong Kong Chinese Version of the St. George Respiratory Questionnaire in Patients With Bronchiectasis Chest, December 1, 2002; 122(6): 2030 - 2037. [Abstract] [Full Text] [PDF]

				J. Roig, X. Soler, C. Domingo, and G. de Celis Serological evidence of Legionella species infection in acute exacerbation of COPD Eur. Respir. J., August 1, 2002; 20(2): 504 - 505. [Full Text] [PDF]

				K. W. Tsang, R. Leung, P. Chin-wan Fung, S. L. Chan, G. L. Tipoe, G. C. Ooi, and W. K. Lam Exhaled and Sputum Nitric Oxide in Bronchiectasis : Correlation With Clinical Parameters Chest, January 1, 2002; 121(1): 88 - 94. [Abstract] [Full Text] [PDF]

				K. W. Tsang, K.-n. Chan, P.-l. Ho, L. Zheng, G. C. Ooi, J. C. M. Ho, and W.-k. Lam Sputum Elastase in Steady-State Bronchiectasis Chest, February 1, 2000; 117(2): 420 - 426. [Abstract] [Full Text] [PDF]

				S. J. Rosenstock, T. Jorgensen, L. P. Andersen, and O. Bonnevie Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults Scand J Public Health, January 1, 2000; 28(1): 32 - 40. [Abstract] [PDF]